SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-18-015625
Filing Date
2018-03-07
Accepted
2018-03-07 18:27:41
Documents
1
Period of Report
2018-03-07

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 2818
  Complete submission text file 0001104659-18-015625.txt   4146
Mailing Address 780 EAST MAIN STREET BRANFORD CT 06405
Business Address 780 EAST MAIN STREET BRANFORD CT 06405 203-643-8060
BioXcel Therapeutics, Inc. (Issuer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 780 EAST MAIN STREET C/O BIOXCEL THERAPEUTICS, INC. BRANFORD CT 06405
Business Address
Yocca Frank (Reporting) CIK: 0001733272 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38410 | Film No.: 18674528